USFDA completes inspection at Alembic Pharmaceuticals’ Oral Solid Formulation Facility

26 Jul 2024 Evaluate

United States Food and Drug Administration (USFDA) has completed GMP inspection at Alembic Pharmaceuticals’ Oral Solid Formulation Facility (F-I) located at Panelav. This was successfully completed without any Form 483 observation. The inspection was conducted from July 17, 2024 to July 26, 2024.

Alembic Pharmaceuticals, a vertically integrated research and development pharmaceutical company, has been at the forefront of Healthcare since 1907.


Alembic Pharma Share Price

1107.65 -40.85 (-3.56%)
06-Sep-2024 16:01 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1823.35
Dr. Reddys Lab 6669.75
Cipla 1614.30
Lupin 2258.00
Zydus Lifesciences 1099.50
View more..
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.